Meril Honored for Best Patent Portfolio at the 10th CII Industrial Intellectual Property Awards 2024

Meril Life Sciences has been honored at the 10th CII Industrial Intellectual Property (IP) Awards 2024, earning the title of Best Patent Portfolio. This recognition underscores Meril’s dedication to pioneering healthcare solutions and its steadfast commitment to advancing innovation in the medical device industry.

As a company deeply rooted in intellectual excellence, Meril has established itself as one of the Top 75 Innovative Companies and a leader in the SME - Manufacturing/Engineering category. These distinctions are a reflection of Meril’s contributions to transforming patient care through groundbreaking innovations.

Meril’s journey of innovation is powered by its global presence, with operations in over 150 countries. The company’s commitment to fostering talent is evident through its 12 academies worldwide, which have helped more than 10,000 healthcare professionals learn modern surgical techniques using cutting-edge surgical simulators and robotics systems.

Aligned with the Make in India initiative, Meril’s state-of-the-art manufacturing facilities play a pivotal role in reducing reliance on imports while delivering world-class medical devices. This focus on accessibility has enabled Meril to lead critical healthcare segments, making advanced treatments available to a global audience.

The recognition at the CII IP Awards marks a significant milestone in Meril’s journey and reinforces its mission to shape the future of healthcare. With unwavering dedication to innovation, Meril continues to deliver on its promise of "More To Life."

Check the IPR Compendium 2024 here.